KR102084635B1 - 튼살방지 조성물 및 그 제조방법 - Google Patents
튼살방지 조성물 및 그 제조방법 Download PDFInfo
- Publication number
- KR102084635B1 KR102084635B1 KR1020180087034A KR20180087034A KR102084635B1 KR 102084635 B1 KR102084635 B1 KR 102084635B1 KR 1020180087034 A KR1020180087034 A KR 1020180087034A KR 20180087034 A KR20180087034 A KR 20180087034A KR 102084635 B1 KR102084635 B1 KR 102084635B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- composition
- stretch
- brown
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 35
- 238000000034 method Methods 0.000 title description 15
- 239000000284 extract Substances 0.000 claims abstract description 37
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 39
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 24
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 239000011780 sodium chloride Substances 0.000 claims description 12
- 235000011187 glycerol Nutrition 0.000 claims description 11
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 claims description 9
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 claims description 9
- 229940100524 ethylhexylglycerin Drugs 0.000 claims description 9
- 241000254109 Tenebrio molitor Species 0.000 claims description 6
- 239000003205 fragrance Substances 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 4
- 235000012054 meals Nutrition 0.000 claims description 3
- 206010040925 Skin striae Diseases 0.000 abstract description 26
- 208000031439 Striae Distensae Diseases 0.000 abstract description 23
- 230000000694 effects Effects 0.000 abstract description 9
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 230000003698 anagen phase Effects 0.000 abstract description 2
- 230000002401 inhibitory effect Effects 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Natural products OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 14
- 210000003491 skin Anatomy 0.000 description 13
- 239000002537 cosmetic Substances 0.000 description 11
- 241000219122 Cucurbita Species 0.000 description 8
- 235000009852 Cucurbita pepo Nutrition 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 235000021329 brown rice Nutrition 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- 238000000605 extraction Methods 0.000 description 5
- 235000014101 wine Nutrition 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 4
- -1 methanol alcohols Chemical class 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 239000000469 ethanolic extract Substances 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 239000000401 methanolic extract Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 231100000241 scar Toxicity 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 102000000589 Interleukin-1 Human genes 0.000 description 2
- 108010002352 Interleukin-1 Proteins 0.000 description 2
- 102000004889 Interleukin-6 Human genes 0.000 description 2
- 108090001005 Interleukin-6 Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 102000011779 Nitric Oxide Synthase Type II Human genes 0.000 description 2
- 108010076864 Nitric Oxide Synthase Type II Proteins 0.000 description 2
- WXPFBYDNONAFBN-UHFFFAOYSA-N O1[SiH2]O[SiH2]O[SiH2]O[SiH2]O[SiH2]1.O1[SiH2]O[SiH2]O[SiH2]O[SiH2]O[SiH2]1 Chemical compound O1[SiH2]O[SiH2]O[SiH2]O[SiH2]O[SiH2]1.O1[SiH2]O[SiH2]O[SiH2]O[SiH2]O[SiH2]1 WXPFBYDNONAFBN-UHFFFAOYSA-N 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000000686 essence Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 229940100601 interleukin-6 Drugs 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 230000037311 normal skin Effects 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- QZLXCFQVOCEKSX-NOCHOARKSA-N (2s,4r)-1-hexadecanoyl-4-hexadecanoyloxypyrrolidine-2-carboxylic acid Chemical compound CCCCCCCCCCCCCCCC(=O)O[C@@H]1C[C@@H](C(O)=O)N(C(=O)CCCCCCCCCCCCCCC)C1 QZLXCFQVOCEKSX-NOCHOARKSA-N 0.000 description 1
- 241000272814 Anser sp. Species 0.000 description 1
- 101710083587 Antifungal protein Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 241000254173 Coleoptera Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000043136 MAP kinase family Human genes 0.000 description 1
- 108091054455 MAP kinase family Proteins 0.000 description 1
- 102000003945 NF-kappa B Human genes 0.000 description 1
- 108010057466 NF-kappa B Proteins 0.000 description 1
- 241000149489 Rhipiceridae Species 0.000 description 1
- 206010053262 Skin swelling Diseases 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 108060002895 fibrillin Proteins 0.000 description 1
- 102000013370 fibrillin Human genes 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- ZGEGCLOFRBLKSE-UHFFFAOYSA-N methylene hexane Natural products CCCCCC=C ZGEGCLOFRBLKSE-UHFFFAOYSA-N 0.000 description 1
- WPHGSKGZRAQSGP-UHFFFAOYSA-N methylenecyclohexane Natural products C1CCCC2CC21 WPHGSKGZRAQSGP-UHFFFAOYSA-N 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229940114496 olive leaf extract Drugs 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
- A61K8/585—Organosilicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Emergency Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
성분(ppm or 중량%) | 실시예 | 비교예 | ||
1 | 1 | 2 | ||
A | 갈색거저리 추출물(ppm) | 0.01 | 0 | 0.005 |
A | 폴리프로필실세스퀴옥산 | 0.2 | 0.2 | 0.2 |
A | 시클로펜타실록산 | 15 | 15 | 15 |
A | PEG-10 | 0.5 | 0.5 | 0.5 |
B | 글리세린 | 0.07 | 0.07 | 0.07 |
B | 에틸헥실글리세린 | 0.07 | 0.07 | 0.07 |
B | 염화나트륨 | 1.5 | 1.5 | 1.5 |
B | 물 | 잔량 | 잔량 | 잔량 |
C | 향료 | 8 | 8 | 8 |
총량(%) | 100 | 100 | 100 |
실험결과(mm) | 1주 | 2주 | 3주 | 4주 | 개선효과 |
실시예 1 | 32.5 | 32.5 | 31.0 | 29.2 | 10.1% |
비교예 1 | 30.5 | 30.5 | 30.4 | 30.2 | 0.9% |
비교예 2 | 34.0 | 34.0 | 33.6 | 33.3 | 2.1% |
Claims (4)
- 갈색거저리(Tenebrio molitor) 추출물을 유효성분으로 포함하고,
상기 갈색거저리 추출물은 튼살 방지 조성물 전체 중량을 기준으로 0.01~10,000ppm로 포함되는 것을 특징으로 하는 튼살 방지 조성물.
- 제1항에 있어서, 폴리프로필실세스퀴옥산(Polypropylsilsesquioxane), 시클로펜타실록산(Cyclopentasiloxane), 프로필렌글리콜(PEG-10), 글리세린(Glycerin), 에틸헥실글리세린(Ethylhexylglycerin), 염화나트륨(Sodium Chloride), 향료 및 물(Water)을 더 포함하는 것을 특징으로 하는 튼살 방지 조성물.
- 삭제
- 삭제
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180087034A KR102084635B1 (ko) | 2018-07-26 | 2018-07-26 | 튼살방지 조성물 및 그 제조방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180087034A KR102084635B1 (ko) | 2018-07-26 | 2018-07-26 | 튼살방지 조성물 및 그 제조방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20200012137A KR20200012137A (ko) | 2020-02-05 |
KR102084635B1 true KR102084635B1 (ko) | 2020-03-04 |
Family
ID=69514574
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020180087034A Active KR102084635B1 (ko) | 2018-07-26 | 2018-07-26 | 튼살방지 조성물 및 그 제조방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102084635B1 (ko) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20220026729A (ko) | 2020-08-26 | 2022-03-07 | 서정현 | 튼살 방지 패치 |
KR20240086404A (ko) | 2022-12-09 | 2024-06-18 | 서정현 | 튼살 방지 패치 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101707107B1 (ko) * | 2015-05-20 | 2017-02-16 | 주식회사 콧데 | 리퀴리티제닌을 활성 성분으로 포함하여 약학적, 화장품적으로 우수하며 다양한 기능성을 보이는 조성물 |
KR101780934B1 (ko) | 2016-07-18 | 2017-09-25 | 대한민국 | 갈색거저리 추출물을 함유하는 탈모방지 또는 발모촉진용 조성물 |
KR101830303B1 (ko) | 2010-12-27 | 2018-02-20 | 다우 코닝 도레이 캄파니 리미티드 | 액체 유기폴리실록산을 함유하는 화장품 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107427447A (zh) * | 2015-03-31 | 2017-12-01 | 株式会社爱茉莉太平洋 | 美妆用化妆品组合物 |
KR20180006699A (ko) * | 2016-07-11 | 2018-01-19 | 휴먼코스메틱 주식회사 | 갈색거저리 추출물을 유효성분으로 함유하는 항산화, 피부 미백 또는 피부 염증성 질환 개선용 화장료 조성물 |
-
2018
- 2018-07-26 KR KR1020180087034A patent/KR102084635B1/ko active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101830303B1 (ko) | 2010-12-27 | 2018-02-20 | 다우 코닝 도레이 캄파니 리미티드 | 액체 유기폴리실록산을 함유하는 화장품 |
KR101707107B1 (ko) * | 2015-05-20 | 2017-02-16 | 주식회사 콧데 | 리퀴리티제닌을 활성 성분으로 포함하여 약학적, 화장품적으로 우수하며 다양한 기능성을 보이는 조성물 |
KR101780934B1 (ko) | 2016-07-18 | 2017-09-25 | 대한민국 | 갈색거저리 추출물을 함유하는 탈모방지 또는 발모촉진용 조성물 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20220026729A (ko) | 2020-08-26 | 2022-03-07 | 서정현 | 튼살 방지 패치 |
KR20240086404A (ko) | 2022-12-09 | 2024-06-18 | 서정현 | 튼살 방지 패치 |
Also Published As
Publication number | Publication date |
---|---|
KR20200012137A (ko) | 2020-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sumit et al. | Herbal cosmetics: Used for skin and hair | |
Desam et al. | The importance of natural products in cosmetics | |
JP6054700B2 (ja) | 脱糖化剤及び皮膚外用剤 | |
JPS60258104A (ja) | 保湿性化粧料組成物 | |
KR102083294B1 (ko) | 피부재생 효과를 갖는 미선나무 추출물 및 그 추출물을 함유하는 피부재생용 조성물 | |
KR102084635B1 (ko) | 튼살방지 조성물 및 그 제조방법 | |
KR20170137552A (ko) | 복합 생약 추출물을 포함하는 피부 개선용 조성물 | |
KR20170137544A (ko) | 복합 생약 추출물을 포함하는 피부 개선용 조성물 | |
KR20240142281A (ko) | 곡물 및 한약재를 이용한 천연 화장료 조성물 | |
KR102020667B1 (ko) | 두피염증 예방 및 완화, 및 탈모방지 효과가 있는 화장료 조성물 | |
KR100753186B1 (ko) | 생약추출 혼합물을 함유하는 피부 노화 방지용 화장료조성물 | |
KR101686008B1 (ko) | 생약 혼합물의 추출물을 함유하는 탈모방지 또는 양모효능이 있는 조성물 | |
KR101799516B1 (ko) | 아토피 피부 개선용 피부 외용제 조성물 및 이를 포함하는 화장품 | |
JP6138317B2 (ja) | 皮膚外用剤 | |
JP2020502172A (ja) | 漢方薬抽出物を有効成分として含む化粧料組成物 | |
KR102214985B1 (ko) | 식물추출물 또는 이의 분획물을 유효성분으로 함유하는 피부 상태 개선용 조성물 | |
KR20170058546A (ko) | 주름개선용 화장료 조성물 | |
KR20210018388A (ko) | 식물추출물 또는 이의 분획물을 유효성분으로 함유하는 피부 상태 개선용 조성물 | |
US20110135772A1 (en) | Skin care agent and compositions thereof | |
KR20170136911A (ko) | 복합 생약 추출물을 포함하는 피부 개선용 조성물 | |
KR20170136389A (ko) | 복합 생약 추출물을 포함하는 피부 개선용 조성물 | |
KR100974268B1 (ko) | 동결건조한 한방 분말을 함유하는 미용팩용 화장품 조성물 | |
KR102124065B1 (ko) | 식물 추출물을 함유하는 피부 주름 개선용 조성물 | |
KR20220134120A (ko) | 천연 원료를 사용한 모발 건강용 트리트먼트 | |
KR20180017974A (ko) | 복합생약추출물을 유효성분으로 함유하는 여드름 예방 또는 치료용 화장료 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20180726 |
|
PA0201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20190704 Patent event code: PE09021S01D |
|
PG1501 | Laying open of application | ||
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20200221 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20200227 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20200228 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20230106 Start annual number: 4 End annual number: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20240110 Start annual number: 5 End annual number: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20250106 Start annual number: 6 End annual number: 6 |